Metformin≥1000mg
Sponsors
Dong-A ST Co., Ltd., Boryung Pharmaceutical Co., Ltd, Yooyoung Pharmaceutical Co., Ltd.
Conditions
Type 2 DiabetesType2 Diabetes
Phase 3
Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
CompletedNCT04356742
Start: 2020-05-26End: 2022-02-23Updated: 2022-03-22
A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
CompletedNCT04885712
Start: 2021-05-28End: 2023-03-10Updated: 2023-05-24
Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients
NCT05226897
Start: 2021-07-12End: 2023-06-26Target: 256Updated: 2022-06-01